Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Autophagy regulators as potential cancer therapeutic agents: a review
Shan Li, Lingfei Wang, Yongzhou Hu
1Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. shengr@zju.edu.cn.
Abstract:
Autophagy is an important basic metabolic mechanism by engulfing and degrading the unnecessary or dysfunctional cellular components within double-membered autolysosomes to maintain cellular homeostasis. Autophagy has sparkled great interest for its complicated functions in different stages of cancer, and is regarded as a potential target for anticancer therapy. As a suppressor pathway, autophagy prevents tumor initiation and as a survival pathway, autophagy contributes to tumor growth and progression by attenuating cellular metabolic stress and resisting therapeutic agents-induced cell death. Many autophagy regulators have been identified as potential cancer therapeutic agents and some cytotoxic anticancer drugs also induce autophagy. Combination regimen of autophagy regulators with other anticancer agent exhibits desirable efficacy and several protocols are underway in clinical trials. This review delineates the possible role of autophagy in anticancer therapy, and discusses reported potent autophagy regulators in cancer treatment.
Insights
Autophagy, a cellular process, plays a dual role in cancer, potentially inhibiting or promoting tumor growth. Targeting autophagy regulators offers a promising strategy for novel anticancer therapies.
Area of Science:
- Cellular Biology
- Oncology
- Metabolic Pathways
Background:
- Autophagy is a fundamental cellular mechanism for maintaining homeostasis by degrading damaged components.
- Its complex roles in cancer, acting as both a tumor suppressor and a promoter, have garnered significant research interest.
- Autophagy's involvement spans from tumor initiation to progression and resistance to therapy.
Purpose of the Study:
- To review the multifaceted role of autophagy in various stages of cancer.
- To discuss the potential of autophagy regulators as anticancer therapeutic agents.
- To highlight current clinical trials involving autophagy-modulating combination therapies.
Main Methods:
- Literature review of autophagy's function in cancer.
- Analysis of identified autophagy regulators for therapeutic potential.
- Examination of combination regimens involving autophagy modulators.
Main Results:
- Autophagy can suppress tumor initiation but also aid tumor growth and survival.
- Autophagy regulators are being explored as cancer therapeutics.
- Cytotoxic drugs often induce autophagy, suggesting complex interactions.
- Combination therapies show promise and are in clinical trials.
Conclusions:
- Autophagy presents a complex target in cancer therapy due to its dual functions.
- Modulating autophagy holds significant potential for developing new anticancer strategies.
- Further research and clinical trials are crucial for optimizing autophagy-based cancer treatments.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

